Sun Pharma gets China NMPA approval for ILUMETRI to treat moderate-to-severe plaque psoriasis Read more
Sun Pharma, Philogen sign pact to commercialise specialty product, NIDLEGY in Europe, Australia and New Zealand Read more
China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData Read more
Eisai to grant 625 mn yen to GHIT Fund for developing medicines for neglected tropical diseases, malaria Read more
Indegene, ConTIPI Medical partner to launch ProVate, a device to treat pelvic organ prolapse in women Read more